UBS’s Select Medical SEM Stock Holding History

UBS’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-1,856	Closed	-$16K	–	10703
2014 Q2	$16K	Buy	1,856 +371	+25%	+$2.88K	﹤0.01%	8361
2014 Q1	$10K	Buy	+1,485	New	+$9K	﹤0.01%	8906

Other funds holding SEM

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

UBS's SEM Position: Q3 2014 in Review

UBS increased its Select Medical (SEM) stake by 200% in Q3 2014, buying an estimated $2.31M and bringing the position to 448,137 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2558.

UBS first reported a position in SEM in Q2 2013 and has held it in 6 quarters since. 168 funds tracked by Wall St. Rank hold SEM as of Q3 2014.

UBS held 448,137 shares of Select Medical worth $2.9M as of Q3 2014.
UBS bought 298,545 Select Medical shares in Q3 2014, an estimated $2.31M.
Select Medical made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2558 holding.
UBS first reported a position in Select Medical in Q2 2013 and has held it in 6 quarters since.
168 funds tracked by Wall St. Rank held Select Medical as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.